Cite
HARVARD Citation
Oort, Q. et al. (2022). Do neurocognitive impairments explain the differences between brain tumor patients and their proxies when assessing the patient's IADL?. Neuro-oncology practice. 9 (4), pp. 271-283. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Oort, Q. et al. (2022). Do neurocognitive impairments explain the differences between brain tumor patients and their proxies when assessing the patient's IADL?. Neuro-oncology practice. 9 (4), pp. 271-283. [Online].